U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C25H26N6O4S.CH4O3S
Molecular Weight 602.682
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TAPRIZOSIN MESYLATE

SMILES

CS(O)(=O)=O.COC1=CC2=C(C(N)=NC(=N2)N3CCC4=C(C3)C=CC=C4NS(C)(=O)=O)C(C5=CC=CC=N5)=C1OC

InChI

InChIKey=PELLFYXDXSYSSE-UHFFFAOYSA-N
InChI=1S/C25H26N6O4S.CH4O3S/c1-34-20-13-19-22(21(23(20)35-2)18-8-4-5-11-27-18)24(26)29-25(28-19)31-12-10-16-15(14-31)7-6-9-17(16)30-36(3,32)33;1-5(2,3)4/h4-9,11,13,30H,10,12,14H2,1-3H3,(H2,26,28,29);1H3,(H,2,3,4)

HIDE SMILES / InChI

Molecular Formula CH4O3S
Molecular Weight 96.106
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C25H26N6O4S
Molecular Weight 506.577
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Taprizosin (also known as UK-338,003) is an alpha1A-adrenoceptor antagonist that was developed for the treatment of benign prostatic hyperplasia. However, this compound possesses poor oral absorption.

Approval Year

PubMed

PubMed

TitleDatePubMed
Impact of physicochemical and structural properties on the pharmacokinetics of a series of alpha1L-adrenoceptor antagonists.
2007 Aug
Investigation of regional mechanisms responsible for poor oral absorption in humans of a modified release preparation of the alpha-adrenoreceptor antagonist, 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4 tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline (UK-338,003): the rational use of ex vivo intestine to predict in vivo absorption.
2008 Jan
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:54:06 UTC 2023
Edited
by admin
on Fri Dec 15 15:54:06 UTC 2023
Record UNII
9YMP2G22X1
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TAPRIZOSIN MESYLATE
Common Name English
METHANESULFONAMIDE, N-(2-(4-AMINO-6,7-DIMETHOXY-5-(2-PYRIDINYL)-2-QUINAZOLINYL)-1,2,3,4-TETRAHYDRO-5-ISOQUINOLINYL)-, METHANESULFONATE
Systematic Name English
Code System Code Type Description
FDA UNII
9YMP2G22X1
Created by admin on Fri Dec 15 15:54:06 UTC 2023 , Edited by admin on Fri Dec 15 15:54:06 UTC 2023
PRIMARY
CAS
358632-25-4
Created by admin on Fri Dec 15 15:54:06 UTC 2023 , Edited by admin on Fri Dec 15 15:54:06 UTC 2023
PRIMARY
PUBCHEM
9830194
Created by admin on Fri Dec 15 15:54:06 UTC 2023 , Edited by admin on Fri Dec 15 15:54:06 UTC 2023
PRIMARY
EPA CompTox
DTXSID60431391
Created by admin on Fri Dec 15 15:54:06 UTC 2023 , Edited by admin on Fri Dec 15 15:54:06 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY